This is the Tagline, edited under "Misc Content"

HEALTHSOUTH Reports Second Quarter Operating EPS Up 33% To $0.28
PRNewswire-FirstCall
BIRMINGHAM, Ala.

HEALTHSOUTH Corporation announced operating results for the quarter and six months ended June 30, 2002. For the second quarter, HEALTHSOUTH's revenues were $1.164 billion, an increase of 5.9% as compared to $1.099 billion for the second quarter of 2001 and an increase of 8.6% after adjusting for divestitures in 2001. Operating earnings for the 2002 quarter were $113.7 million, an increase of 36.8% compared to operating earnings of $83.1 million in the 2001 quarter. Operating earnings per share (assuming dilution) were $0.28 for the 2002 quarter, consistent with consensus Wall Street estimates, an increase of 33.3% as compared to operating earnings per share (assuming dilution) of $0.21 in the 2001 quarter. For the quarter, the Company's earnings before interest, taxes, depreciation and amortization (EBITDA) margin, excluding unusual and non-recurring items, was 29.8%, compared to 28.1% in the second quarter of 2001.

For the six months ended June 30, 2002, HEALTHSOUTH's revenues were $2.293 billion, compared to $2.189 billion for the 2001 period. Operating earnings for the 2002 period were $221.4 million, an increase of 39.8% compared to operating earnings of $158.4 million for the 2001 period. The comparable operating earnings per share (assuming dilution) for the 2002 period were $0.55, compared to operating earnings per share (assuming dilution) of $0.40 for the 2001 period.

Operating earnings exclude the effects of certain items that are included in net income, including unusual and non-recurring items and changes in accounting principles. Including the effects of these items, net income was $57.5 million or $0.14 per diluted share versus a net loss of $19.9 million or ($0.05) per diluted share for the 2001 quarter. For the six months ended June 30, 2002, net income was $82.1 million or $0.20 per diluted share compared to $55.4 million or $0.14 per diluted share in the 2001 period. A reconciliation of operating earnings to net income as determined under generally accepted accounting principles is provided in the accompanying financial information.

Management believes that operating earnings and operating earnings per share excluding such unusual and non-recurring items and non-cash impairment charges provide a clearer picture of the Company's operational performance than net income and earnings per share standing alone. Unusual and non-recurring items in the second quarter totaled approximately $56.2 million, net of income taxes. These items included a loss of approximately $52.8 million on the previously announced disposition of five nursing homes and a loss of $3.4 million related to the early extinguishment of debt.

"The second quarter showed strength across all product lines with each of our businesses demonstrating continued positive volume and pricing trends," said Richard M. Scrushy, Chairman of the Board and Chief Executive Officer of HEALTHSOUTH. "We were especially pleased with the performance of our inpatient rehabilitation facilities as they generated an 11% increase in revenue. This clearly demonstrates the success we are having under the new Prospective Payment System."

Scrushy added, "Additionally, we completed the final stage of our refinancing plan with the successful completion of a $1 billion note offering and a $1.25 billion revolving credit facility. This financing provides us with ample liquidity to meet the 2003 maturity of our convertible debentures. Subsequent to quarter-end, we have repurchased approximately $220 million of our outstanding debt securities, and we still have availability of $1.2 billion under our new credit facility. We have also used the recent weakness in our stock price to reactivate our share repurchase program and have been actively accumulating shares."

At June 30, 2002, the Company's balance sheet reflected total debt of $3.480 billion and cash and cash equivalents of $547 million, resulting in net debt of $2.933 billion. Total debt and net debt at June 30, 2002 reflect the funding of $207 million in expenditures during the quarter to acquire certain properties previously held under synthetic operating leases. Excluding the effect of funding such expenditures, net debt decreased $55 million in the quarter in comparison to net debt at March 31, 2002. Accounts receivable days declined 2.5 days to 79 days from the first quarter of 2002.

Cash flow from operations totaled approximately $235 million compared to $159 million in the 2001 quarter. Capital spending was approximately $137 million in the quarter, excluding the $207 million expenditure to acquire the properties held under synthetic operating leases.

On January 1, 2002, HEALTHSOUTH adopted Financial Accounting Standards Board Statement No. 142, which requires the periodic testing of goodwill for impairment rather than a monthly amortization of goodwill. The results for the 2002 quarter reflect the adoption of this new policy. Had the policy been in effect in 2001, reported net income would have increased by $12.0 million, or $.03 per share (assuming dilution), in the second quarter of 2001. During the quarter the Company and its auditors completed their testing of goodwill for impairment under FASB 142 and the Company recognized a goodwill impairment of $83.2 million, net of tax. The effects of this impairment are reflected as the cumulative effect of a change in accounting principle in the Company's results of operations for the six months ended June 30, 2002.

HEALTHSOUTH is the nation's largest provider of outpatient surgery, diagnostic imaging and rehabilitative healthcare services, with approximately 1,900 locations in all 50 states, the United Kingdom, Australia, Puerto Rico and Canada. HEALTHSOUTH can be found on the Web at http://www.healthsouth.com/.

HEALTHSOUTH will hold a conference call to discuss its second quarter results at 9:00 a.m. Central Daylight Time on Wednesday, August 7. Simultaneously with the conference call, a webcast of the call will be available to interested parties at http://www.healthsouth.com/ via an Internet link under the "Investor Relations" section. A replay of the call will be available at the same Internet site address for 15 days following the call.

Statements contained in this press release which are not historical facts are forward-looking statements. Without limiting the generality of the preceding statement, all statements in this press release concerning or relating to estimated and projected earnings, margins, costs, expenditures, cash flows, growth rates and financial results are forward-looking statements. In addition, HEALTHSOUTH, through its senior management, may from time to time make forward-looking public statements concerning the matters described herein. Such forward-looking statements are necessarily estimates based upon current information, involve a number of risks and uncertainties and are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. HEALTHSOUTH's actual results may differ materially from the results anticipated in these forward-looking statements as a result of a variety of factors, including those identified in this press release and in the public filings made by HEALTHSOUTH with the Securities and Exchange Commission, including HEALTHSOUTH's Annual Report on Form 10-K for the year ended December 31, 2001 and its Quarterly Reports on Form 10-Q, and forward-looking statements contained in this press release or in other public statements of HEALTHSOUTH or its senior management should be considered in light of those factors. There can be no assurance that such factors or other factors will not affect the accuracy of such forward-looking statements.

   HEALTHSOUTH Corporation and Subsidiaries
   CONSOLIDATED STATEMENTS OF INCOME
   (UNAUDITED - In thousands, except per share amounts)

                               Three Months Ended      Six Months Ended
                                    June 30,                June 30,
                                2002        2001        2002        2001

  Revenues                   $1,163,683  $1,098,989  $2,293,458  $2,189,451

  Operating unit expenses       747,412     722,705   1,483,813   1,458,750
  Corporate general and
   administrative expenses       43,291      51,214      83,257      83,868
  Provision for doubtful
   accounts                      25,642      34,858      50,636      59,241
  Depreciation and amortization  79,807      93,223     157,389     184,442
  Early extinguishment
   of debt                        5,534       6,475       5,534       6,475
  Loss on sale of assets         76,690     139,883      76,690     139,883
  Interest expense               52,892      55,247     100,935     114,667
  Interest income                (1,204)     (1,591)     (2,267)     (4,312)
                              1,030,064   1,102,014   1,955,987   2,043,014
    Income (loss) before
     income taxes and
     minority interests         133,619      (3,025)    337,471     146,437

  Provision (benefit)
   for income taxes              45,782      (7,636)    113,950      41,534
    Income before minority
     interests                   87,837       4,611     223,521     104,903
  Minority interests            (30,331)    (24,558)    (58,266)    (49,539)

  Income (loss) before
   cumulative effect of
    accounting change            57,506     (19,947)    165,255      55,364
  Cumulative effect of
   accounting change                 --          --     (83,165)         --
    Net income (loss)           $57,506    $(19,947)    $82,090     $55,364

  Weighted average common
   shares outstanding           395,302     388,665     393,559     388,463

  Income (loss) per common
   share before cumulative
   effect of accounting change     0.15       (0.05)       0.42        0.14
  Cumulative effect of
   accounting change                 --          --       (0.21)         --
  Net income (loss) per
   common share                   $0.15      $(0.05)      $0.21       $0.14

  Weighted average common
   shares outstanding --
   assuming dilution            402,472     388,665     400,896     397,993

  Income (loss) per common
   share before cumulative
   effect of accounting
   change -- assuming dilution     0.14       (0.05)       0.41        0.14
  Cumulative effect of
   accounting change                 --          --       (0.21)         --
  Net income (loss) per common
   share -- assuming dilution     $0.14      $(0.05)      $0.20       $0.14

  Add-back to income for
   diluted earnings per
   share:  Interest and
   amortization on
   convertible debt.                $--         $--         $--         $--

                                     *           *           *           *
  *  The effect of these securities
      was antidilutive.

  Income (loss) per common
   share before cumulative
   effect of accounting change  $57,506    $(19,947)   $165,255     $55,364

  Add back non-recurring items
    Non-recurring items          82,224     164,906      82,224     164,906
    Tax benefit                 (26,049)    (61,880)    (26,049)    (61,880)

  Adjusted net income          $113,681     $83,079    $221,430    $158,390

  Weighted average common
   shares outstanding           395,302     388,665     393,559     388,463

  Weighted average common shares
    outstanding -- assuming
     dilution                   417,973     397,500     416,398     397,993

  Net income per common share     $0.29       $0.21       $0.56       $0.41

  Net income per common
   share -- assuming dilution     $0.28       $0.21       $0.55       $0.40

  Add-back to income for
   diluted earnings per
   share:  Interest and
   amortization on
   convertible debt              $3,164         $--      $6,294         $--
                                                 *                       *

  *  The effect of these securities
      was antidilutive.


   HEALTHSOUTH Corporation and Subsidiaries
   Consolidated Statements of Income Before Unusual and Non-Recurring Items
   (UNAUDITED - In thousands, except per share amounts)

                            Three Months Ended         Six Months Ended
                                  June 30,                 June 30,
                             2002         2001         2002         2001

   Revenues               $1,163,683   $1,098,989   $2,293,458   $2,189,451

   Operating unit expenses   747,412      722,705    1,483,813    1,458,750
   Corporate general and
    administrative expenses   43,291       42,966       83,257       75,620
   Provision for doubtful
    accounts                  25,642       24,558       50,636       48,941
   Depreciation and
    amortization              79,807       93,223      157,389      184,442
   Interest expense           52,892       55,247      100,935      114,667
   Interest income            (1,204)      (1,591)      (2,267)      (4,312)
                             947,840      937,108    1,873,763    1,878,108
   Income before income
    taxes and minority
    interests                215,843      161,881      419,695      311,343
   Provision for income
    taxes                     71,831       54,244      139,999      103,414
   Income before minority
    interests                144,012      107,637      279,696      207,929
   Minority interests        (30,331)     (24,558)     (58,266)     (49,539)
   Net income               $113,681      $83,079     $221,430     $158,390

   Weighted average common
    shares outstanding       395,302      388,665      393,559      388,463

   Net income per common
    share                      $0.29        $0.21        $0.56        $0.41

   Weighted average common
    shares outstanding -
    assuming dilution        417,973      397,500      416,398      397,993

   Net income per common
    share - assuming
    dilution                   $0.28        $0.21        $0.55        $0.40

   Add-back to income for
    diluted earnings per share:
     Interest and amortization
      on convertible debt     $3,164           --       $6,294           --

                                               *                         *

   *  The effect of these securities
       was antidilutive.


   HEALTHSOUTH Corporation and Subsidiaries
   Consolidated Statements of Income
   Six Months Ended June 30, 2002
   (UNAUDITED - In thousands, except per share amounts)

                                                                 Six Months
                                                                    Ended
                                                                   June 30,
                                                                     2002
                                                      Less          Before
                                                     Unusual        Unusual
                                       Six Months    and Non-       and Non-
                                         Ended      Recurring      Recurring
                                     June 30, 2002    Items          Items

  Revenues                            $2,293,458                 $2,293,458
  Operating unit expenses              1,483,813                  1,483,813
  Corporate general and
   administrative expenses                83,257                     83,257
  Provision for doubtful accounts         50,636                     50,636
  Depreciation and amortization          157,389                    157,389
  Early extinguishment of debt             5,534      5,534 (1)          --
  Loss on sale of assets                  76,690     76,690 (2)          --
  Interest expense                       100,935                    100,935
  Interest income                         (2,267)                    (2,267)
                                       1,955,987     82,224       1,873,763
  Income before income taxes,
   minority interests and cumulative
   effect of accounting change           337,471    (82,224)        419,695
  Provision for income taxes             113,950    (26,049)        139,999
  Income before minority interests
   and cumulative effect
   of accounting change                  223,521    (56,175)        279,696

  Minority interests                     (58,266)                   (58,266)
  Income before cumulative
   effect of accounting change           165,255    (56,175)        221,430
  Cumulative effect of accounting change (83,165)   (83,165)             --
  Net income                             $82,090  $(139,340)       $221,430

  Weighted average common
   shares outstanding                    393,559                    393,559

  Income per common share before
   cumulative effect of accounting change   0.42                       0.56
  Cumulative effect of accounting change   (0.21)                        --
  Net income per common share              $0.21                      $0.56

  Weighted average common shares
     outstanding -- assuming dilution    400,896                    416,398

  Income per common share before
   cumulative effect of accounting
   change -- assuming dilution              0.41                       0.55
  Cumulative effect of accounting change   (0.21)                        --
  Net income per common
   share -- assuming dilution              $0.20                      $0.55

  Add-back to income for diluted
   earnings per share:
     Interest and amortization on
      convertible debt *                      --                     $6,294
                                              *

  *  The effect of these securities
      was antidilutive.

  (1) Impairment charge related to the write-off of the unamortized balance
      of loan fees on retired debt.
  (2) Loss related to the sale of certain facilities.


   HEALTHSOUTH Corporation and Subsidiaries
   Consolidated Statements of Income
   Three Months Ended June 30, 2002
   (UNAUDITED - In thousands, except per share amounts)

                                                                Three Months
                                                                    Ended
                                                                   June 30,
                                                                     2002
                                                      Less          Before
                                                     Unusual        Unusual
                                      Three Months    and Non-      and Non-
                                         Ended      Recurring      Recurring
                                     June 30, 2002    Items          Items

  Revenues                            $1,163,683                 $1,163,683
  Operating unit expenses                747,412                    747,412
  Corporate general and
   administrative expenses                43,291                     43,291
  Provision for doubtful accounts         25,642                     25,642
  Depreciation and amortization           79,807                     79,807
  Early extinguishment of debt             5,534     5,534 (1)           --
  Loss on sale of assets                  76,690    76,690 (2)           --
  Interest expense                        52,892                     52,892
  Interest income                         (1,204)                    (1,204)
                                       1,030,064    82,224          947,840
  Income before income taxes and
     minority interests                  133,619   (82,224)         215,843
  Provision for income taxes              45,782   (26,049)          71,831
  Income before minority interests        87,837   (56,175)         144,012
  Minority interests                     (30,331)                   (30,331)
  Net income                             $57,506  $(56,175)        $113,681

  Weighted average common
   shares outstanding                    395,302                    395,302

  Net income per common share              $0.15                      $0.29

  Weighted average common shares
     outstanding -- assuming dilution    402,472                    417,973

  Net income per common share -
     assuming dilution                     $0.14                      $0.28

  Add-back to income for diluted
   earnings per share:
     Interest and amortization on
       convertible debt *                     --                     $3,164
                                              *

  * The effect of these securities
     was antidilutive

  (1) Impairment charge related to the write-off of the unamortized balance
      of loan fees on retired debt.
  (2) Loss related to the sale of certain facilities.



   HEALTHSOUTH Corporation and Subsidiaries
   BALANCE SHEET
   (UNAUDITED - In thousands)

                                                June 30,        December 31,
                                                  2002              2001
  ASSETS
  Cash and Cash Equivalents                     $546,864          $278,456
  Accounts Receivable, net                     1,010,083           940,414
  Other Current Assets                           464,858           517,585
     Total Current Assets                      2,021,805         1,736,455

  Net Property and Equipment                   3,064,617         2,774,736
  Net Intangibles                              2,659,399         2,725,103
  Other                                          385,777           342,943

  Total Assets                                $8,131,598        $7,579,237

  LIABILITIES AND STOCKHOLDERS' EQUITY
  Accounts Payable                                29,682            37,085
  Other Current Liabilities                      270,161           299,999
  Current Maturities of Long-Term Debt           589,662            21,912
     Total Current Liabilities                   889,505           358,996

  Long-Term Debt                               2,889,863         3,005,035
  Other                                          257,058           263,741
  Minority Interests                             161,966           154,541

  Stockholders' Equity                         3,933,206         3,796,924

  Total Liabilities and Stockholder's Equity  $8,131,598        $7,579,237


   HEALTHSOUTH Corporation
   Quarterly Statistics (Unaudited)
  For Period Ending June 30, 2002

                                                   2Q 2002        2Q 2001
  Outpatient Rehab
  Total Visits:                                  2,400,046      2,249,908
  Total Volume Growth (Y/Y):                           6.7%
  Same Store Volume Growth (Y/Y):                      6.5%
  Average Revenue per Visit:                          $100            $95
  Facility Count:                                    1,427          1,432

  Surgery Centers
  Total Cases:                                     230,746        225,512
  Total Volume Growth (Y/Y):                           2.3%
  Same Store Volume Growth (Y/Y):                      4.8%
  Average Revenue per Case:                         $1,146         $1,097
  Facility Count:                                      209            216

  Diagnostic Imaging
  Total Scans:                                     278,262        274,623
  Total Volume Growth (Y/Y):                          1.3%
  Same Store Volume Growth (Y/Y):                     5.6%
  Average Revenue per Scan:                           $318           $318
  Facility Count:                                      136            140

  Inpatient Division
  Total Discharges:                                 29,873         28,307
  Total Volume Growth (Y/Y):                           5.5%
  Same Store Volume Growth (Y/Y):                      5.2%
  Average Revenue per Discharge:                   $16,257        $15,425
  Facility Count:                                      118            120

  Medical Centers (Revised to Exclude Richmond Medical Center)
  Total Days:                                       24,293         24,243
  Total Volume Growth (Y/Y):                           0.2%
  Same Store Volume Growth (Y/Y):                      0.2%
  Average Revenue per Day:                          $2,999         $2,953
  Facility Count:                                        4              4


For more information, contact Richard M. Scrushy, Chairman & CEO, or Tadd McVay, Executive Vice President and Treasurer at 205-967-7116

MAKE YOUR OPINION COUNT - Click Here
http://tbutton.prnewswire.com/prn/11690X92453162

SOURCE: HEALTHSOUTH Corporation

CONTACT: Richard M. Scrushy, Chairman & CEO, or Tadd McVay, Executive
Vice President and Treasurer, both of HEALTHSOUTH Corporation, 205-967-7116